PPARD and invasive breast carcinoma: Furthermore, BRCA patients in the PPAR-δ-high group and in the M0 subgroup had a worse OS (P = 0.002), thus indicating that PPAR-δ has a greater prognostic role in BRCA patients without distant metastasis (Figures 5C-G).